BridgeBio Oncology Therapeutics, Inc. (BBOT)
NASDAQ: BBOT · Real-Time Price · USD
13.69
+2.15 (18.63%)
At close: Dec 5, 2025, 4:00 PM EST
13.75
+0.06 (0.44%)
After-hours: Dec 5, 2025, 7:48 PM EST
BBOT Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
| Selling, General & Admin | 21.63 | 7.76 | 8.49 |
| Research & Development | 102.67 | 73.11 | 56.29 |
| Operating Expenses | 124.29 | 80.86 | 64.77 |
| Operating Income | -124.29 | -80.86 | -64.77 |
| Interest & Investment Income | 9.05 | 6.38 | 0.07 |
| Other Non Operating Income (Expenses) | 0.3 | 0.21 | - |
| Pretax Income | -114.93 | -74.28 | -64.7 |
| Net Income | -114.93 | -74.28 | -64.7 |
| Net Income to Common | -114.93 | -74.28 | -64.7 |
| Shares Outstanding (Basic) | 11 | 0 | 0 |
| Shares Outstanding (Diluted) | 11 | 0 | 0 |
| Shares Change (YoY) | 8840.04% | 16.36% | - |
| EPS (Basic) | -10.31 | -511.80 | -518.73 |
| EPS (Diluted) | -10.31 | -511.80 | -518.73 |
| Free Cash Flow | -87.24 | -55.08 | -52.49 |
| Free Cash Flow Per Share | -7.82 | -379.51 | -420.87 |
| EBITDA | -124.04 | -80.66 | -64.68 |
| D&A For EBITDA | 0.25 | 0.21 | 0.09 |
| EBIT | -124.29 | -80.86 | -64.77 |
Source: S&P Capital IQ. Standard template.
Financial Sources.